官方服务：
资源简介：
Treatment of C3H/HeJ grafted mice with baricitinib
应用场景：
创建时间：
2015-05-01
相关数据集
Relative proportions of significantly different bacterial genera in Tnf -/- mice.
Superscript letters across rows denote significant difference at P<0.05 determined using Mann Whitney U test. “Unclassified” are taxa in the families listed that are yet to be classified with a genus
NIAID Data Ecosystem80
Gene expression profile of the RAG2/pfp gene depletion on Thymus of mouse. Gene expression profile of the RAG2/pfp gene depletion on Thymus of mouse
It contains a disruption of the recombination activating gene 2 (RAG2)/pfp and fail to generate mature T or B or NK lymphocytes. (https://www.taconic.com) Overall design: Gene expression profiling of
NIAID Data Ecosystem20
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
Though Janus kinase inhibitors such as upadacitinib rapidly relieve itch in atopic dermatitis (AD) patients, how early itch relief impacts later skin clearance is not examined. This study aims to det
NIAID Data Ecosystem10
Bladder weights and inhibitory rates observed in 4 BALB/c-nu mice (%).
(Compared with the normal saline group: **P<0.01) Bladder weights and inhibitory rates observed in 4 BALB/c-nu mice (%).
NIAID Data Ecosystem80
FDA/EMA Dosing Regimens for JAKi Use for Pediatric Indications
This table summarizes the recommended dosing regimens for JAK inhibitors approved for pediatric indications by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
DataCite Commons2026-03-18 更新10
